Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Novel Immunomagnetic Cell Separation Platform to Bioseparation Portfolio
MENLO PARK, Calif., Jan. 15, 2021 /PRNewswire/ -- Gamma Biosciences , a life sciences tool platform created by KKR, has agreed to acquire State College, Pennsylvania based, BioMagnetic Solutions (BMS) , a next-generation cell selection and bioseparation technology company.
- MENLO PARK, Calif., Jan. 15, 2021 /PRNewswire/ -- Gamma Biosciences , a life sciences tool platform created by KKR, has agreed to acquire State College, Pennsylvania based, BioMagnetic Solutions (BMS) , a next-generation cell selection and bioseparation technology company.
- BMS has developed advanced immunomagnetic cell separation systems using nanoscale ferrofluids for highly specific cell selection and other bioseparation applications.
- The ferrofluid based affinity sorting reagents can be integrated into single-use magnetic separation platforms ( X-GRAFFE ) at research, clinical, and commercial scale.
- A pioneer inbioseparations, BioMagnetic Solutions' platforms and products leverage next generation nano-magnetic ferrofluids that enable superior performance compared withexisting immunomagnetic cell separation systems.